Claris Bio

StemSight

This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.

Amber Ophthalmics

The company develops biopharmaceutical therapies to treat rare anterior segment eye diseases such as persistent corneal epithelial defects for patients.

Ollin Bio

This biotechnology company develops bispecific antibody therapies for patients with vision-threatening conditions such as macular degeneration and thyroid eye disease.

Trefoil Therapeutics

The company develops engineered protein therapies to treat corneal endothelial and epithelial diseases for patients with vision loss or ocular surface damage.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Cirrus Therapeutics

This company develops gene and cell therapies to treat age-related macular degeneration and chronic vision loss for patients with blinding eye diseases.

Envisia

This clinical-stage biotechnology company develops extended-release ocular therapies for patients with glaucoma and other eye disorders.